Current View on the Mechanism of Action of Perifosine in Cancer

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 17, 14 Issues, 2017

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Current View on the Mechanism of Action of Perifosine in Cancer

Anti-Cancer Agents in Medicinal Chemistry, 14(4): 629-635.

Author(s): Joachim Fensterle, Babette Aicher, Irene Seipelt, Michael Teifel and Juergen Engel.

Affiliation: Aeterna Zentaris, Weismuellerstr. 50, 60314 Frankfurt, Germany.


Perifosine treatment exhibits a complex molecular response including the inhibition of Akt or the induction of apoptosis via clustering of death receptors in lipid rafts. However, the molecular response can vary between different tumor entities and the contribution of each target pathway to the activity of Perifosine might be distinct depending on the tumor entity or the agent combined with Perifosine.

In this review we discuss the current view on the mechanism of action of perifosine in cancer and the contribution of the molecular targets of Perifosine to its activity.


APL miltefosine, cancer, perifosine.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 14
Issue Number: 4
First Page: 629
Last Page: 635
Page Count: 7
DOI: 10.2174/1871520614666140309225912
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science